23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › BIOATLA INC. › 2023-2024

BIOATLA INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and BIOATLA INC.’s Form 8-K, filed June 13, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 3Ballot items
  • 103Asset managers, any item
  • 404Fund votes
  • June 13, 2024Meeting date

Results at a glance

Meeting of June 13, 2024: 3 items on BIOATLA INC.’s Form 8-K, filed June 13, 2024: 2 approved · 1 passed (calculated).

Dissent

Significant dissent: 1 director (33.3% against).

Notable dissent: 1 say-on-pay vote (77.5% support).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024

Explore BIOATLA INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by BIOATLA INC.

These tallies are BIOATLA INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BIOATLA INC. — official shareholder meeting results, meeting held June 13, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Sylvia McBrinn 15,280,856---- 7,634,07511,599,001 67%Passed (calculated)—
2. Ratification of Appointment of Independent Registered Public Accounting Firm 34,271,982106,553135,397 ---- 99.7%Approved—
3. Non-Binding Advisory Vote on the Executive Compensation of Our Named Executive Officers 17,643,4385,121,016153,387 --11,596,091 78%Approved—

Source: BIOATLA INC., Form 8-K, filed with the SEC on June 13, 2024 — read the filing on EDGAR.

How asset managers voted at the BIOATLA INC. 2023-2024 meeting

103 asset managers disclosed a vote on at least one BIOATLA INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Sylvia McBrinn

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 2 wordings of this item as funds reported it.

67% Majority: yes · of votes cast

FOR 67%WITHHELD
FOR: 15,280,856WITHHELD: 7,634,075
Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: Elect the Class I director listed in the accompanying Proxy Statement, to serve a three-year term expiring at the 2027 annual meeting of stockholders or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal: Sylvia McBrinn

BIOATLA INC.’s own tally for this item (“Elect Director: Sylvia McBrinn”): 15,280,856 for, 7,634,075 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 67% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 36 asset managers below reported 3,590,657 for, 1,494,827 withheld.

FORWITHHOLD
FOR: 3,590,657WITHHOLD: 1,494,827
Largest asset managers voting on “Elect the Class I director listed in the accompanying Proxy Statement, to serve a three-year term expiring at ” at BIOATLA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,067,8450 00For
BlackRock722,4510 00For
DWS00 0676,915Withhold
MFS00 0447,519Withhold
ETF Opportunities Trust191,9500 00For
TIAA171,8650 00For
Charles Schwab119,5490 00For
BRIDGEWAY FUNDS INC00 090,000Withhold
QUANTITATIVE MASTER SERIES LLC87,4330 00For
Dimensional00 077,850Withhold
Equitable59,4920 08,360Mixed
Pacific Life17,3050 041,727Mixed
Fidelity39,8280 00For
Prudential/PGIM00 039,112Withhold
Lincoln Financial37,9000 00For
American Century00 033,720Withhold
Managed Portfolio Series29,8050 00For
AIG/SunAmerica00 021,799Withhold
Bridge Builder Trust17,9170 00For
Voya14,8050 00For
John Hancock00 013,342Withhold
HC CAPITAL TRUST00 011,191Withhold
Principal Exchange-Traded Funds00 07,792Withhold
ProShares00 07,179Withhold
Nationwide1,8230 03,617Mixed

Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).

Non-Binding Advisory Vote on the Executive Compensation of Our Named Executive Officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

78% Approved · of votes cast

FOR 78%AGAINST
FOR: 17,643,438AGAINST: 5,121,016

Prior year: 95.2% for (June 14, 2023 meeting) ▼ 17.7 pts

Details: description as filed, official tally, votes by 103 asset managers

Description as filed by funds: APPROVE, BY A NON-BINDING ADVISORY VOTE, THE EXECUTIVE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

BIOATLA INC.’s own tally for this item (“3. Non-Binding Advisory Vote on the Executive Compensation of Our Named Executive Officers”): 17,643,438 for, 5,121,016 against — passed, per its Form 8-K filed June 13, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Three - Non-Binding Advisory Vote on the Executive Compensation of Our Named Executive Officers The Company's stockholders approved, on a non-binding advisory basis, the executive compensation of our named executive officers by the following votes:”
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 36 asset managers voting on “APPROVE, BY A NON-BINDING ADVISORY VOTE, THE EXECUTIVE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at BIOATLA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,067,8450 00For
BlackRock722,4510 00For
DWS676,9150 00For
MFS0447,519 00Against
ETF Opportunities Trust191,9500 00For
TIAA171,8650 00For
Charles Schwab119,5490 00For
BRIDGEWAY FUNDS INC090,000 00Against
QUANTITATIVE MASTER SERIES LLC87,4330 00For
Dimensional077,850 00Against
Equitable67,8520 00For
Pacific Life17,30541,727 00Mixed
Fidelity39,8280 00For
Prudential/PGIM039,112 00Against
Lincoln Financial37,9000 00For
American Century033,720 00Against
Managed Portfolio Series29,8050 00For
AIG/SunAmerica21,7990 00For
Bridge Builder Trust17,9170 00For
Voya14,8050 00For
John Hancock13,3420 00For
HC CAPITAL TRUST011,191 00Against
Principal Exchange-Traded Funds7,7920 00For
ProShares7,1790 00For
Nationwide5,4400 00For

Fund voting reports, all 36 managers: 4,339,483 for, 746,001 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 78 asset managers voting on “APPROVE, BY A NON-BINDING ADVISORY VOTE, THE EXECUTIVE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at BIOATLA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Soleus Capital Management, L.P.3,894,2920 00For
BlackRock932,7410 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/0528,358 00Against
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND512,3000 00For
State Street451,680751 00For
Renaissance300,2580 00For
Connor, Clark & Lunn Investment Management Ltd.228,8860 00For
PNC BANK, NATIONAL ASSOCIATION210,8740 00For
Northern Trust182,107461 00For
MELLON INVESTMENTS Corp177,9890 00For
Nuveen177,8520 00For
UBS137,4860 00For
Two Sigma120,9380 00For
Charles Schwab119,5490 00For
BRIDGEWAY CAPITAL MANAGEMENT, LLC090,000 00Against
CHASE INVESTMENT COUNSEL CORP76,7420 00For
Manatuck Hill Partners, LLC75,0000 00For
Citadel74,8990 00For
PERCEPTIVE ADVISORS LLC73,0000 00For
BROWN ADVISORY INC64,0140 00For
GEODE CAPITAL MANAGEMENT, LLC54,2980 00For
ACADIAN ASSET MANAGEMENT LLC49,3660 00For
JPMorgan47,2840 00For
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM041,259 00Against
Dimensional039,793 00Against

Institutional-manager reports, all 78 managers: 8,239,854 for, 803,565 against. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of Appointment of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.7% Approved · of votes cast

FOR 99.7%
FOR: 34,271,982AGAINST: 106,553

Prior year: 98.5% for (June 14, 2023 meeting) ▲ 1.2 pts

Details: description as filed, official tally, votes by 36 asset managers

Description as filed by funds: Ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of BioAtla, Inc. for the fiscal year ending December 31, 2024.

BIOATLA INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm”): 34,271,982 for, 106,553 against — passed, per its Form 8-K filed June 13, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Two - Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 by the following votes:”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 36 asset managers below reported 5,085,484 for.

FOR
FOR: 5,085,484
Largest asset managers voting on “Ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of BioAtla, I” at BIOATLA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,067,8450 00For
BlackRock722,4510 00For
DWS676,9150 00For
MFS447,5190 00For
ETF Opportunities Trust191,9500 00For
TIAA171,8650 00For
Charles Schwab119,5490 00For
BRIDGEWAY FUNDS INC90,0000 00For
QUANTITATIVE MASTER SERIES LLC87,4330 00For
Dimensional77,8500 00For
Equitable67,8520 00For
Pacific Life59,0320 00For
Fidelity39,8280 00For
Prudential/PGIM39,1120 00For
Lincoln Financial37,9000 00For
American Century33,7200 00For
Managed Portfolio Series29,8050 00For
AIG/SunAmerica21,7990 00For
Bridge Builder Trust17,9170 00For
Voya14,8050 00For
John Hancock13,3420 00For
HC CAPITAL TRUST11,1910 00For
Principal Exchange-Traded Funds7,7920 00For
ProShares7,1790 00For
Nationwide5,4400 00For

Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).

Largest BIOATLA INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 48,106,317 shares outstanding at the time of that meeting.

Fund voting reports: top BIOATLA INC. shareholders by shares voted on “APPROVE, BY A NON-BINDING ADVISORY VOTE, THE EXECUTIVE COMPENSATION OF OUR NAMED EXECUTIVE…”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 4.30%
2BlackRock 1.50%
3DWS 1.41%
4MFS 0.93%
5ETF Opportunities Trust 0.40%
6TIAA 0.36%
7Charles Schwab 0.25%
8BRIDGEWAY FUNDS INC 0.19%
9QUANTITATIVE MASTER SERIES LLC 0.18%
10Dimensional 0.16%
Institutional-manager reports: top BIOATLA INC. shareholders by shares voted on “APPROVE, BY A NON-BINDING ADVISORY VOTE, THE EXECUTIVE COMPENSATION OF OUR NAMED EXECUTIVE…”, 2023-2024
#Asset manager % of shares outstanding
1Soleus Capital Management, L.P. 8.10%
2BlackRock 1.94%
3MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.10%
4HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 1.06%
5State Street 0.94%
6Renaissance 0.62%
7Connor, Clark & Lunn Investment Management Ltd. 0.48%
8PNC BANK, NATIONAL ASSOCIATION 0.44%
9Northern Trust 0.38%
10MELLON INVESTMENTS Corp 0.37%

Reported BIOATLA INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

BIOATLA INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Acorn Bioventures, L.P.4,032,046 8.38%Proxy statement (DEF 14A), proxy filed April 24, 2024
Entities affiliated with Soleus Private Equity Fund I, L.P.3,901,314 8.11%Proxy statement (DEF 14A), proxy filed April 24, 2024
Entities affiliated with Cormorant Asset Management3,680,365 7.65%Proxy statement (DEF 14A), proxy filed April 24, 2024
Jay M. Short, Ph.D.3,534,313 7.35%Proxy statement (DEF 14A), proxy filed April 24, 2024
Tang Capital Partners, LP2,524,076 5.25%Proxy statement (DEF 14A), proxy filed April 24, 2024
Vanguard Group1,945,795 4.04%Form 13F, quarter ended March 31, 2024
Renaissance Technologies996,300 2.07%Form 13F, quarter ended March 31, 2024
Geode Capital922,938 1.92%Form 13F, quarter ended March 31, 2024
Millennium Management873,654 1.82%Form 13F, quarter ended March 31, 2024
State Street791,278 1.64%Form 13F, quarter ended March 31, 2024

Percentages above are of 48,106,317 shares outstanding, as reported by BIOATLA INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At BIOATLA INC.'s shareholder meeting held June 13, 2024, in the 2023-2024 proxy season, 103 asset managers reported votes on at least one of its 3 ballot items in their SEC Form N-PX filings, covering 404 separate fund positions. On the most widely held item on that ballot — APPROVE, BY A NON-BINDING ADVISORY VOTE, THE EXECUTIVE COMPENSATION OF OUR NAMED EXECUTIVE… — BIOATLA INC.'s filing reports the proposal as approved, with 78% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: BIOATLA INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIOATLA INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

BIOATLA INC. proxy season coverage: 2023-2024 (this page).

Cite this page

Proxy Votes Now, “BIOATLA (BCAB) 2024 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/bioatla-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.